Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier

Hypertension

Volumn 63, Issue 3, 2014, Pages 572-579

  Biancardi, Vinicia Campana ^a   Son, Sook Jin ^a   Ahmadi, Sahra ^a   Filosa, Jessica A ^a   Stern, Javier E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

angiotensin II; blood brain barrier; brain stem; hypertension; hypothalamus; receptor, angiotensin, type 1

Indexed keywords

ANGIOTENSIN II; BLOOD-BRAIN BARRIER; BRAIN STEM; HYPERTENSION; HYPOTHALAMUS; RECEPTOR, ANGIOTENSIN, TYPE 1;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BRAIN STEM; DISEASE MODELS, ANIMAL; HYPERTENSION; HYPOTHALAMUS; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR;

EID: 84894433066     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01743     Document Type: Article

References (66)

1. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335-346.
2. McKinley MJ, McAllen RM, Pennington GL, Smardencas A, Weisinger RS, Oldfield BJ. Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain. Clin Exp Pharmacol Physiol Suppl. 1996;3:S99-S104.
3. Zardetto-Smith AM, Thunhorst RL, Cicha MZ, Johnson AK. Afferent signaling and forebrain mechanisms in the behavioral control of extracellular fluid volume. Ann N Y Acad Sci. 1993;689:161-176.
4. Smith PM, Ferguson AV. Circulating signals as critical regulators of autonomic state-central roles for the subfornical organ. Am J Physiol Regul Integr Comp Physiol. 2010;299:R405-R415.
5. Ferguson AV, Bains JS. Actions of angiotensin in the subfornical organ and area postrema: Implications for long term control of autonomic output. Clin Exp Pharmacol Physiol. 1997;24:96-101.
6. Anderson JW, Smith PM, Ferguson AV. Subfornical organ neurons projecting to paraventricular nucleus: Whole-cell properties. Brain Res. 2001;921:78-85.
7. Bains JS, Potyok A, Ferguson AV. Angiotensin II actions in paraventricular nucleus: Functional evidence for neurotransmitter role in efferents originating in subfornical organ. Brain Res. 1992;599:223-229.
8. Tagawa T, Dampney RA. AT(1) receptors mediate excitatory inputs to rostral ventrolateral medulla pressor neurons from hypothalamus. Hypertension. 1999;34:1301-1307.
9. Osborn JW, Fink GD, Sved AF, Toney GM, Raizada MK. Circulating angiotensin II and dietary salt: Converging signals for neurogenic hypertension. Curr Hypertens Rep. 2007;9:228-235.
10. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C, Raizada MK. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56:297-303.
11. Waki H, Gouraud SS, Maeda M, Raizada MK, Paton JF. Contributions of vascular inflammation in the brainstem for neurogenic hypertension. Respir Physiol Neurobiol. 2011;178:422-428.
12. Waubant E. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis Markers. 2006;22:235-244.
13. Yang Y, Rosenberg GA. MMP-mediated disruption of claudin-5 in the blood-brain barrier of rat brain after cerebral ischemia. Methods Mol Biol. 2011;762:333-345.
14. Mayhan WG, Faraci FM, Siems JL, Heistad DD. Role of molecular charge in disruption of the blood-brain barrier during acute hypertension. Circ Res. 1989;64:658-664.
15. Ueno M, Sakamoto H, Liao YJ, Onodera M, Huang CL, Miyanaka H, Nakagawa T. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol. 2004;122:131-137.
16. Vital SA, Terao S, Nagai M, Granger DN. Mechanisms underlying the cerebral microvascular responses to angiotensin II-induced hypertension. Microcirculation. 2010;17:641-649.
17. Pelisch N, Hosomi N, Ueno M, Nakano D, Hitomi H, Mogi M, Shimada K, Kobori H, Horiuchi M, Sakamoto H, Matsumoto M, Kohno M, Nishiyama A. Blockade of AT1 receptors protects the blood-brain barrier and improves cognition in Dahl salt-sensitive hypertensive rats. Am J Hypertens. 2011;24:362-368.
18. Rodrigues SF, Granger DN. Cerebral microvascular inflammation in DOCA salt-induced hypertension: Role of angiotensin II and mitochondrial superoxide. J Cereb Blood Flow Metab. 2012;32:368-375.
19. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension: I. the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347-379.
20. Koprdova R, Cebova M, Kristek F. Long-Term effect of losartan administration on blood pressure, heart and structure of coronary artery of young spontaneously hypertensive rats. Physiol Res. 2009;58:327-335.
21. Shi YX, Chen Y, Zhu YZ, Huang GY, Moore PK, Huang SH, Yao T, Zhu YC. Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2007;293:H2093-H2100.
22. Gumerlock MK, Neuwelt EA. The effects of anesthesia on osmotic bloodbrain barrier disruption. Neurosurgery. 1990;26:268-277.
23. Marchi N, Betto G, Fazio V, Fan Q, Ghosh C, Machado A, Janigro D. Blood-brain barrier damage and brain penetration of antiepileptic drugs: Role of serum proteins and brain edema. Epilepsia. 2009;50:664-677.
24. Yao ST, May CN. Intra-carotid angiotensin II activates tyrosine hydroxylase-expressing rostral ventrolateral medulla neurons following bloodbrain barrier disruption in rats. Neuroscience. 2013;245:148-156.
25. Biancardi VC, Campos RR, Stern JE. Altered balance of gamma-Aminobutyric acidergic and glutamatergic afferent inputs in rostral ventrolateral medulla-projecting neurons in the paraventricular nucleus of the hypothalamus of renovascular hypertensive rats. J Comp Neurol. 2010;518:567-585.
26. Mayhan WG. Leukocyte adherence contributes to disruption of the bloodbrain barrier during activation of mast cells. Brain Res. 2000;869:112-120.
27. Norsted E, Goddddmüç B, Meister B. Protein components of the blood-brain barrier (BBB) in the mediobasal hypothalamus. J Chem Neuroanat. 2008;36:107-121.
28. Krum JM. Effect of astroglial degeneration on neonatal blood-brain barrier marker expression. Exp Neurol. 1996;142:29-35.
29. Hofman P, Hoyng P, vanderWerf F, Vrensen GF, Schlingemann RO. Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci. 2001;42:895-901.
30. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989;13(6 Pt 2):968-972.
31. Cates MJ, Dickinson CJ, Hart EC, Paton JF. Neurogenic hypertension and elevated vertebrobasilar arterial resistance: Is there a causative link?. Curr Hypertens Rep. 2012;14:261-269.
32. Lin SZ, Sposito N, Pettersen S, Rybacki L, McKenna E, Pettigrew K, Fenstermacher J. Cerebral capillary bed structure of normotensive and chronically hypertensive rats. Microvasc Res. 1990;40:341-357.
33. Sternberger NH, Sternberger LA, Kies MW, Shear CR. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis. J Neuroimmunol. 1989;21:241-248.
34. Abdel-Rahman A, Shetty AK, Abou-Donia MB. Acute exposure to sarin increases blood brain barrier permeability and induces neuropathological changes in the rat brain: Dose-response relationships. Neuroscience. 2002;113:721-741.
35. Averill DB, Diz DI. Angiotensin peptides and baroreflex control of sympathetic outflow: Pathways and mechanisms of the medulla oblongata. Brain Res Bull. 2000;51:119-128.
36. Veerasingham SJ, Raizada MK. Brain renin-Angiotensin system dysfunction in hypertension: Recent advances and perspectives. Br J Pharmacol. 2003;139:191-202.
37. Benicky J, Sánchez-Lemus E, Pavel J, Saavedra JM. Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery. Cell Mol Neurobiol. 2009;29:781-792.
38. Harwani SC, Chapleau MW, Legge KL, Ballas ZK, Abboud FM. Neurohormonal modulation of the innate immune system is proinflammatory in the prehypertensive spontaneously hypertensive rat, a genetic model of essential hypertension. Circ Res. 2012;111:1190-1197.
39. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophiltype NAD(P)H oxidase in smooth muscle cells from human resistance arteries: Regulation by angiotensin II. Circ Res. 2002;90:1205-1213.
40. Helderman F, Segers D, de Crom R, Hierck BP, Poelmann RE, Evans PC, Krams R. Effect of shear stress on vascular inflammation and plaque development. Curr Opin Lipidol. 2007;18:527-533.
41. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab. 2009;29:640-647.
42. Agarwal D, Welsch MA, Keller JN, Francis J. Chronic exercise modulates RAS components and improves balance between pro-And anti-inflammatory cytokines in the brain of SHR. Basic Res Cardiol. 2011;106:1069-1085.
43. Gutkind JS, Kurihara M, Castren E, Saavedra JM. Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive rats. J Hypertens. 1988;6:79-84.
44. Raizada MK, Sumners C, Lu D. Angiotensin II type 1 receptor mRNA levels in the brains of normotensive and spontaneously hypertensive rats. J Neurochem. 1993;60:1949-1952.
45. Reja V, Goodchild AK, Phillips JK, Pilowsky PM. Upregulation of angiotensin at(1) receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol. 2006;33:690-695.
46. Huang J, Hara Y, Anrather J, Speth RC, Iadecola C, Pickel VM. Angiotensin II subtype 1A (AT1A) receptors in the rat sensory vagal complex: Subcellular localization and association with endogenous angiotensin. Neuroscience. 2003;122:21-36.
47. Ito H, Takemori K, Suzuki T. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens. 2001;19(3 Pt 2):591-597.
48. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91:461-553.
49. Paton JF, Lonergan T, Deuchars J, James PE, Kasparov S. Detection of angiotensin II mediated nitric oxide release within the nucleus of the solitary tract using electron-paramagnetic resonance (EPR) spectroscopy. Auton Neurosci. 2006;126-127:193-201.
50. Bui JD, Kimura B, Phillips MI. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier. Eur J Pharmacol. 1992;219:147-151.
51. Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats. Eur J Pharmacol. 1999;367:255-265.
52. Wang JM, Tan J, Leenen FH. Central nervous system blockade by peripheral administration of AT1 receptor blockers. J Cardiovasc Pharmacol. 2003;41:593-599.
53. Paton JF, Wang S, Polson JW, Kasparov S. Signalling across the blood brain barrier by angiotensin II: Novel implications for neurogenic hypertension. J Mol Med (Berl). 2008;86:705-710.
54. Bains JS, Ferguson AV. Paraventricular nucleus neurons projecting to the spinal cord receive excitatory input from the subfornical organ. Am J Physiol. 1995;268(3 Pt 2):R625-R633.
55. Ferguson AV. Angiotensinergic regulation of autonomic and neuroendocrine outputs: Critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology. 2009;89:370-376.
56. Zhu GQ, Patel KP, Zucker IH, Wang W. Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats. Am J Physiol Heart Circ Physiol. 2002;282:H2039-H2045.
57. Chen AD, Zhang SJ, Yuan N, Xu Y, De W, Gao XY, Zhu GQ. Angiotensin AT1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats. Exp Physiol. 2011;96:94-103.
58. Ito S, Komatsu K, Tsukamoto K, Kanmatsuse K, Sved AF. Ventrolateral medulla AT1 receptors support blood pressure in hypertensive rats. Hypertension. 2002;40:552-559.
59. Matsumura K, Averill DB, Ferrario CM. Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflex. Am J Physiol. 1998;275(5 Pt 2):R1611-R1619.
60. Cato MJ, Toney GM. Angiotensin II excites paraventricular nucleus neurons that innervate the rostral ventrolateral medulla: An in vitro patchclamp study in brain slices. J Neurophysiol. 2005;93:403-413.
61. Latchford KJ, Ferguson AV. ANG II-induced excitation of paraventricular nucleus magnocellular neurons: A role for glutamate interneurons. Am J Physiol Regul Integr Comp Physiol. 2004;286:R894-R902.
62. Li YW, Guyenet PG. Neuronal excitation by angiotensin II in the rostral ventrolateral medulla of the rat in vitro. Am J Physiol. 1995;268(1 Pt 2):R272-R277.
63. Barnes KL, DeWeese DM, Andresen MC. Angiotensin potentiates excitatory sensory synaptic transmission to medial solitary tract nucleus neurons. Am J Physiol Regul Integr Comp Physiol. 2003;284:R1340-R1353.
64. Füchtbauer L, Groth-Rasmussen M, Holm TH, Løbner M, Toft-Hansen H, Khorooshi R, Owens T. Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system. Brain Behav Immun. 2011;25:897-904.
65. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: Redefining the functional architecture of the brain. Trends Neurosci. 2003;26:523-530.
66. Savoia C, Schiffrin EL. Inflammation in hypertension. Curr Opin Nephrol Hypertens. 2006;15:152-158.